Physician profile
Scott E Margolis
NPI 1740216852
$3,849.20
in general payments reported to CMS, 2019-2025
35 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $484 · 2021: $523 · 2022: $179 · 2023: $708 · 2024: $797 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,994.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,281.28 | 2019-2025 | Augment Injectable, Hoffmann |
| Horizon Therapeutics Plc | $476.59 | 2019-2023 | Krystexxa |
| Bone Support INC. | $164.68 | 2021 | |
| Osiris Therapeutics INC. | $152.78 | 2019 | |
| Alafair Biosciences, INC. | $151.20 | 2024 | Versawrap |
| Smith+Nephew, INC. | $123.41 | 2019-2025 | Renasys Touch, Renasys Go V2 Home, Collagenase Santyl |
| Tactile Systems Technology INC | $116.27 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Nevro Corp. | $114.39 | 2023-2024 | Senza |
| Amgen INC. | $110.71 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $109.67 | 2020-2025 | Nuzyra |
| Comsort, INC | $100.00 | 2019 | |
| Melinta Therapeutics, LLC | $93.66 | 2019 | |
| Medinc of Texas | $87.09 | 2025 | |
| Reddress USA, INC. | $80.06 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $68.55 | 2020-2023 | Jublia |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $66.53 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $54.94 | 2019 | |
| Ani Pharmaceuticals, INC. | $51.50 | 2025 | Purified Cortrophin Gel |
| Averitas Pharma INC. | $48.79 | 2023-2024 | Qutenza |
| Innovation Technologies INC | $47.19 | 2023-2024 | Irrisept |
| Merck Sharp & Dohme LLC | $44.33 | 2019 | |
| Sandoz INC. | $43.45 | 2019-2020 | |
| Misonix INC | $29.77 | 2019 | |
| Grt US Holding, INC. | $27.61 | 2022 | |
| Wright Medical Technology, INC. | $23.24 | 2019 | |
| Reprise Biomedical, INC. | $21.18 | 2024 | Miro3d |
| Aroa Biosurgery Incorporated | $20.86 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.56 | 2021 | |
| Inari Medical, INC. | $20.29 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heron Therapeutics, INC. | $18.90 | 2023 | Zynrelef |
| Resmed Corp | $18.38 | 2023 | |
| Treace Medical Concepts, INC. | $16.80 | 2022 | |
| Arteriocyte Medical Systems, INC. | $15.33 | 2022 | |
| Cashflow Solutions, LLC | $14.85 | 2024 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Kci USA, INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Margolis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.